Novartis AG, the drugmaker that plans to launch four major medicines, will open a US$100 million research center in Shanghai next year to attract Chinese talent to replenish its product pipeline.
The site, set to become the eighth in the company's research network, will be staffed by scientists recruited from Shanghai-based institutions, Novartis said yesterday.
The new facility will allow the company to benefit from the growing number of highly skilled Chinese scientists, chief executive officer Daniel Vasella said. That may give the Basel, Switzerland-based company an advantage in finding new products at a time when best-selling drugs are going off-patent and research costs soar.
"The most important aspect is that in Shanghai there is a pool of scientific talent emerging," Vasella said in a telephone interview on Sunday.
The site will also help Novartis build contacts to research institutions and doctors in a key market. Worldwide drug sales will rise 5 percent to 6 percent next year to as much as US$685 billion, according to a report last month by research firm IMS Health Inc. China will be one of the fastest-growing markets, increasing 15 percent to 16 percent to about US$16 billion next year.
In China about 85 percent of people pay for drugs themselves, so makers aren't pressured by insurers or the government to lower prices as much as in other parts of the world.
Swiss rival Roche Holding AG runs two factories and one research facility in China. Roche said China revenue is estimated to reach 400 million Swiss francs (US$319 million) this year, driven by sales of the drugs.
In May, AstraZeneca Plc, the UK's second-largest drugmaker, said it would spend US$100 million in the next three years on research in China.
Novartis plans to introduce new treatments for diabetes, cancer and two for hypertension. Analysts expect the products each to bring sales of more than US$1 billion a year. The shares have outpaced larger rivals GlaxoSmithKline Plc and Sanofi-Aventis SA because of growth in heart drug Diovan and tumor-busting Gleevec.
Scientists at the Novartis center will study diseases including cancers caused by infections. Experts estimate hepatitis-induced liver cancer causes the death of 300,000 people in China each year.
The institute will open a smaller facility in May next year, the company said, before starting work on laboratories for 400 scientists.
The center will be headed by En Li, a native of Shanghai who now works at Novartis' Boston research site. The institute will also draw native Chinese returning from abroad, Fishman said.
It may take three years before the performance of the research can be reviewed, and about 12 to 15 years for it to develop new medicines, Vasella said. A similar research institute in India is "unlikely," Vasella said.
Novartis' predecessor Ciba opened its first office in Shanghai in 1938 to sell dyes, and the company is the fourth-largest supplier to Chinese hospitals. Novartis collaborates with the Shanghai Institute of Materia Medica to test traditional medicines, among other partnerships.
In his National Day Rally speech on Sunday, Singaporean Prime Minister Lawrence Wong (黃循財) quoted the Taiwanese song One Small Umbrella (一支小雨傘) to describe his nation’s situation. Wong’s use of such a song shows Singapore’s familiarity with Taiwan’s culture and is a perfect reflection of exchanges between the two nations, Representative to Singapore Tung Chen-yuan (童振源) said yesterday in a post on Facebook. Wong quoted the song, saying: “As the rain gets heavier, I will take care of you, and you,” in Mandarin, using it as a metaphor for Singaporeans coming together to face challenges. Other Singaporean politicians have also used Taiwanese songs
NORTHERN STRIKE: Taiwanese military personnel have been training ‘in strategic and tactical battle operations’ in Michigan, a former US diplomat said More than 500 Taiwanese troops participated in this year’s Northern Strike military exercise held at Lake Michigan by the US, a Pentagon-run news outlet reported yesterday. The Michigan National Guard-sponsored drill involved 7,500 military personnel from 36 nations and territories around the world, the Stars and Stripes said. This year’s edition of Northern Strike, which concluded on Sunday, simulated a war in the Indo-Pacific region in a departure from its traditional European focus, it said. The change indicated a greater shift in the US armed forces’ attention to a potential conflict in Asia, it added. Citing a briefing by a Michigan National Guard senior
CHIPMAKING INVESTMENT: J.W. Kuo told legislators that Department of Investment Review approval would be needed were Washington to seek a TSMC board seat Minister of Economic Affairs J.W. Kuo (郭智輝) yesterday said he received information about a possible US government investment in Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) and an assessment of the possible effect on the firm requires further discussion. If the US were to invest in TSMC, the plan would need to be reviewed by the Department of Investment Review, Kuo told reporters ahead of a hearing of the legislature’s Economics Committee. Kuo’s remarks came after US Secretary of Commerce Howard Lutnick on Tuesday said that the US government is looking into the federal government taking equity stakes in computer chip manufacturers that
CLAMPING DOWN: At the preliminary stage on Jan. 1 next year, only core personnel of the military, the civil service and public schools would be subject to inspections Regular checks are to be conducted from next year to clamp down on military personnel, civil servants and public-school teachers with Chinese citizenship or Chinese household registration, the Mainland Affairs Council (MAC) said yesterday. Article 9-1 of the Act Governing Relations Between the People of the Taiwan Area and the Mainland Area (臺灣地區與大陸地區人民關係條例) stipulates that Taiwanese who obtain Chinese household registration or a Chinese passport would be deprived of their Taiwanese citizenship and lose their right to work in the military, public service or public schools, it said. To identify and prevent the illegal employment of holders of Chinese ID cards or
RSS